10X Genomics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $153,104 | $141,006 | $183,979 | $153,644 |
Gross Profit | 106,896 | 95,569 | 106,065 | 95,529 |
EBITDA | -30,837 | -47,904 | -23,904 | -91,743 |
EBIT | -41,737 | -59,398 | -35,610 | -103,163 |
Net Income | -37,897 | -59,949 | -48,952 | -92,986 |
Net Change In Cash | 153,104 | 141,006 | 183,979 | 153,644 |
Free Cash Flow | 3,618 | -18,635 | 22,308 | -40,740 |
Cash | 379,824 | 355,781 | 359,284 | 311,264 |
Basic Shares | 120,066 | 119,394 | 118,565 | 117,728 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $618,727 | $516,409 | $490,490 | $298,845 |
Gross Profit | 409,313 | 396,023 | 416,399 | 240,377 |
EBITDA | -158,249 | -161,495 | -53,509 | -82,455 |
EBIT | -201,868 | -194,501 | -81,763 | -101,476 |
Net Income | -255,099 | -166,000 | -58,223 | -542,731 |
Net Change In Cash | 618,727 | 516,409 | 490,490 | 298,845 |
Cost of Revenue | -368,676 | -92,805 | 212,614 | |
Free Cash Flow | -64,721 | -165,267 | -122,651 | -256,292 |
Cash | 359,284 | 219,746 | 587,447 | 663,603 |
Basic Shares | 117,165 | 113,858 | 110,347 | 101,151 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.30 |
2024-06-30 | -$0.32 |
2024-03-31 | -$0.50 |
2023-12-31 | -$0.41 |
